Literature DB >> 19240757

B-cell responses to vaccination at the extremes of age.

Claire-Anne Siegrist1, Richard Aspinall.   

Abstract

Infants and the elderly share a high vulnerability to infections and therefore have specific immunization requirements. Inducing potent and sustained B-cell responses is as challenging in infants as it is in older subjects. Several mechanisms to explain the decreased B-cell responses at the extremes of age apply to both infants and the elderly. These include intrinsic B-cell limitations as well as numerous microenvironmental factors in lymphoid organs and the bone marrow. This Review describes the mechanisms that shape B-cell responses at the extremes of age and how they could be taken into account to design more effective immunization strategies for these high-risk age groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240757     DOI: 10.1038/nri2508

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  112 in total

1.  Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice.

Authors:  Shuhua Han; Kaiyong Yang; Zeynep Ozen; Weiyi Peng; Ekaterina Marinova; Garnett Kelsoe; Biao Zheng
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

2.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

3.  Serum immunoglobulin levels in healthy children and adults.

Authors:  J W Stoop; B J Zegers; P C Sander; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells.

Authors:  Daniela Frasca; Diep Nguyen; Richard L Riley; Bonnie B Blomberg
Journal:  Mech Ageing Dev       Date:  2003-04       Impact factor: 5.432

5.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

6.  Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.

Authors:  Ray Borrow; David Goldblatt; Adam Finn; Joanna Southern; Lindsey Ashton; Nick Andrews; Gouri Lal; Christine Riley; Rukhsana Rahim; Keith Cartwright; Geraldine Allan; Elizabeth Miller
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 7.  Biology of immune responses to vaccines in elderly persons.

Authors:  Birgit Weinberger; Dietmar Herndler-Brandstetter; Angelika Schwanninger; Daniela Weiskopf; Beatrix Grubeck-Loebenstein
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

8.  Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2.

Authors:  A W Griffioen; G T Rijkers; P Janssens-Korpela; B J Zegers
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

Authors:  Maria Mamani-Matsuda; Antonio Cosma; Sandra Weller; Ahmad Faili; Caroline Staib; Loïc Garçon; Olivier Hermine; Odile Beyne-Rauzy; Claire Fieschi; Jacques-Olivier Pers; Nina Arakelyan; Bruno Varet; Alain Sauvanet; Anne Berger; François Paye; Jean-Marie Andrieu; Marc Michel; Bertrand Godeau; Pierre Buffet; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Blood       Date:  2008-03-03       Impact factor: 22.113

10.  APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.

Authors:  Elodie Belnoue; Maria Pihlgren; Tracy L McGaha; Chantal Tougne; Anne-Françoise Rochat; Claudia Bossen; Pascal Schneider; Bertrand Huard; Paul-Henri Lambert; Claire-Anne Siegrist
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

View more
  245 in total

1.  Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.

Authors:  Eric Giannoni; Laurence Guignard; Marlies Knaup Reymond; Matthieu Perreau; Matthias Roth-Kleiner; Thierry Calandra; Thierry Roger
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Vaccination: the present and the future.

Authors:  Saheli Sadanand
Journal:  Yale J Biol Med       Date:  2011-12

3.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

Review 4.  The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens.

Authors:  C R Dunston; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.

Authors:  Roudaina Nasser; Mireia Pelegrin; Henri-Alexandre Michaud; Marc Plays; Marc Piechaczyk; Laurent Gros
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 6.  Age effects on B cells and humoral immunity in humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Bonnie B Blomberg
Journal:  Ageing Res Rev       Date:  2010-08-20       Impact factor: 10.895

7.  Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.

Authors:  Adrian J Reber; Jin Hyang Kim; Renata Biber; H Keipp Talbot; Laura A Coleman; Tatiana Chirkova; F Liaini Gross; Evelene Steward-Clark; Weiping Cao; Stacie Jefferson; Vic Veguilla; Eric Gillis; Jennifer Meece; Yaohui Bai; Heather Tatum; Kathy Hancock; James Stevens; Sarah Spencer; Jufu Chen; Paul Gargiullo; Elise Braun; Marie R Griffin; Maria Sundaram; Edward A Belongia; David K Shay; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

Review 8.  Impact of host genetic polymorphisms on vaccine induced antibody response.

Authors:  Janina E Linnik; Adrian Egli
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

9.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Authors:  Eileen Goodwin; Morgan S A Gilman; Daniel Wrapp; Man Chen; Joan O Ngwuta; Syed M Moin; Patricia Bai; Arvind Sivasubramanian; Ruth I Connor; Peter F Wright; Barney S Graham; Jason S McLellan; Laura M Walker
Journal:  Immunity       Date:  2018-02-03       Impact factor: 31.745

10.  Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Authors:  Juan Carlos Tinoco; Christine Juergens; Guillermo M Ruiz Palacios; Jorge Vazquez-Narvaez; Hermann Leo Enkerlin-Pauwells; Vani Sundaraiyer; Sudam Pathirana; Elena Kalinina; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Clin Vaccine Immunol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.